c) 2022-Scopus Open Access (PDF)

Permanent URI for this collectionhttps://dspace.psgrkcw.com/handle/123456789/3734

Browse

Subject: search.filters.subject.molecular docking

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    EVALUATION OF THE SYNTHESIZED NOVEL IRIDIUM (III) COMPLEXES AGAINST HELA CELL LINES THROUGH IN-SILICO, IN-VITRO AND DNA NICKING
    (Asia Pacific Journal of Research, 2022) Sathya Priyadarshini, G; Aathi, Muthusankar; Ramesh, Subramani; Selvi, Gopal
    Globally, the pharmaceutical industry is continuously driven in search of new anticancer drugs due to increasing rate of cancer patients. Clinical trials of Cisplatin has been explored, however, usage of Cisplatin as a drug is limited due to its various side effects, hence, alternative to platinum based complex drugs and its analogues are needed. Iridium complexes have been attracted widespread interests by virtue of their pharmacological and photo-physical properties; however the less number of complexes was reported in the literature. In this article, a new series of novel Iridium (III) complexes were synthesized using substituted quinoline Schiff Base (SB) ligands and characterized by spectroscopic techniques. The in- vitro cyto-toxicity assay showed that the Iridium (III) complex activity is equal to standard Cisplatin. In addition, computational docking studies have shown that the prominent binding sites for synthesized complexes against HeLa cell lines, which is comparable with standard Cisplatin drugs and other Ruthenium complexes.
  • Thumbnail Image
    Item
    TRANSCRIPTOMICS, CHEMINFORMATICS, AND SYSTEMS PHARMACOLOGY STRATEGIES UNVEIL THE POTENTIAL BIOACTIVES TO COMBAT COVID-19
    (MDPI, 2022-09-13) Sivakumar, Adarshan; Sakthivel, Akassh; Krishnakumar, Avinash; Mathivanan, Bharathkumar; Pandiyan, Muthuramalingam; Hyunsuk, Shin; Venkidasamy, Baskar; Jen-Tsung, Chen; Veluswamy, Bhuvaneshwari; Manikandan, Ramesh
    Coronavirus disease (COVID-19) is a viral disease caused by the SARS-CoV-2 virus and is becoming a global threat again because of the higher transmission rate and lack of proper therapeutics as well as the rapid mutations in the genetic pattern of SARS-CoV-2. Despite vaccinations, the prevalence and recurrence of this infection are still on the rise, which urges the identification of potential global therapeutics for a complete cure. Plant-based alternative medicine is becoming popular worldwide because of its higher efficiency and minimal side effects. Yet, identifying the potential medicinal plants and formulating a plant-based medicine is still a bottleneck. Hence, in this study, the systems pharmacology, transcriptomics, and cheminformatics approaches were employed to uncover the multi-targeted mechanisms and to screen the potential phytocompounds from significant medicinal plants to treat COVID-19. These approaches have identified 30 unique COVID-19 human immune genes targeted by the 25 phytocompounds present in four selected ethnobotanical plants. Differential and co-expression profiling and pathway enrichment analyses delineate the molecular signaling and immune functional regulations of the COVID-19 unique genes. In addition, the credibility of these compounds was analyzed by the pharmacological features. The current holistic finding is the first to explore whether the identified potential bioactives could reform into a drug candidate to treat COVID-19. Furthermore, the molecular docking analysis was employed to identify the important bioactive compounds; thus, an ultimately significant medicinal plant was also determined. However, further laboratory evaluation and clinical validation are required to determine the efficiency of a therapeutic formulation against COVID-19.